CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Houston, Texas, United States and 83 other locations
to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) in front-line, PD-L1-high, locally advanced or metastatic Non-Small Cell Lung...
Phase 2
Houston, Texas, United States and 116 other locations
and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer...
Phase 2
Kingwood, Texas, United States and 46 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
Houston, Texas, United States and 12 other locations
of carboplatin and paclitaxel) and radiation in patients with lung cancer.You are being asked to take part in this study because yo ...
Phase 2
Houston, Texas, United States
This is a Phase 2, multi-center, open-label study to evaluate the safety and efficacy of VGT-309, a tumor-targeted, activatable fluorescent ...
Phase 2
Houston, Texas, United States and 5 other locations
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Houston, Texas, United States and 30 other locations
N2) NSCLC (per the 8th International Association for the Study of Lung Cancer classification). The primary objective of this study ...
Phase 2
Houston, Texas, United States and 8 other locations
sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) with high programmed cell death protein lig...
Phase 2
Houston, Texas, United States and 60 other locations
The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The aims of this study are to see how safe an...
Phase 2
Houston, Texas, United States and 54 other locations
Clinical trials
Research sites
Resources
Legal